235 related articles for article (PubMed ID: 23887604)
1. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
[TBL] [Abstract][Full Text] [Related]
2. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis.
Pawitan Y; Yin L; Setiawan A; Auer G; Smedby KE; Czene K
Eur J Cancer; 2015 Apr; 51(6):751-7. PubMed ID: 25726091
[TBL] [Abstract][Full Text] [Related]
4. [Aspirin against cancer].
Mabro M; de Gramont A
Rev Med Interne; 2000 Mar; 21 Suppl 1():60s-67s. PubMed ID: 10763206
[TBL] [Abstract][Full Text] [Related]
5. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
6. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
Rothwell PM; Wilson M; Price JF; Belch JF; Meade TW; Mehta Z
Lancet; 2012 Apr; 379(9826):1591-601. PubMed ID: 22440947
[TBL] [Abstract][Full Text] [Related]
7. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
8. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.
Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ
Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563
[TBL] [Abstract][Full Text] [Related]
9. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Coyle C; Cafferty FH; Rowley S; MacKenzie M; Berkman L; Gupta S; Pramesh CS; Gilbert D; Kynaston H; Cameron D; Wilson RH; Ring A; Langley RE;
Contemp Clin Trials; 2016 Nov; 51():56-64. PubMed ID: 27777129
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.
Walker AJ; Grainge MJ; Card TR
Br J Cancer; 2012 Oct; 107(9):1602-7. PubMed ID: 23011483
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
[TBL] [Abstract][Full Text] [Related]
12. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.
Elwood PC; Morgan G; Pickering JE; Galante J; Weightman AL; Morris D; Kelson M; Dolwani S
PLoS One; 2016; 11(4):e0152402. PubMed ID: 27096951
[TBL] [Abstract][Full Text] [Related]
13. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Cardwell CR; Flahavan EM; Hughes CM; Coleman HG; O'Sullivan JM; Powe DG; Murray LJ
Cancer Causes Control; 2014 Jan; 25(1):33-43. PubMed ID: 24310109
[TBL] [Abstract][Full Text] [Related]
16. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
17. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
18. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
Cuzick J; Otto F; Baron JA; Brown PH; Burn J; Greenwald P; Jankowski J; La Vecchia C; Meyskens F; Senn HJ; Thun M
Lancet Oncol; 2009 May; 10(5):501-7. PubMed ID: 19410194
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
